• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《患者组织来源的FGFR4变体和野生型结直肠癌类器官发育及抗癌药物敏感性测试》勘误[《Heliyon》第10卷，第10期，2024年5月，文章编号e30985]

Corrigendum to "Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing" [Heliyon Vol 10, Iss 10, May 2024, Article e30985].

作者信息

Lin Hailing, Fu Hongbo, Sun Shishen, Yin Hao, Yuan Jie, Liao Jilin

机构信息

Department of Pharmacy, The Second Affiliated Hospital, Shantou University Medical College, Shantou, 515041, Guangdong, China.

Department of General Surgery, Foshan Clinical Medical School, Guangzhou University of Chinese Medicine, Foshan, 528000, Guangdong, China.

出版信息

Heliyon. 2024 Nov 15;10(23):e39990. doi: 10.1016/j.heliyon.2024.e39990. eCollection 2024 Dec 15.

DOI:10.1016/j.heliyon.2024.e39990
PMID:39759853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700674/
Abstract

[This corrects the article DOI: 10.1016/j.heliyon.2024.e30985.].

摘要

[本文更正了文章的数字对象标识符：10.1016/j.heliyon.2024.e30985。]

相似文献

1
Corrigendum to "Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing" [Heliyon Vol 10, Iss 10, May 2024, Article e30985].《患者组织来源的FGFR4变体和野生型结直肠癌类器官发育及抗癌药物敏感性测试》勘误[《Heliyon》第10卷，第10期，2024年5月，文章编号e30985]
Heliyon. 2024 Nov 15;10(23):e39990. doi: 10.1016/j.heliyon.2024.e39990. eCollection 2024 Dec 15.
2
Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing.患者组织来源的FGFR4变体和野生型结直肠癌类器官的发育及抗癌药物敏感性测试。
Heliyon. 2024 May 14;10(10):e30985. doi: 10.1016/j.heliyon.2024.e30985. eCollection 2024 May 30.
3
Corrigendum to "" [Heliyon Vol. 9, Iss. 1, January 2023, Article e12599].《“”的勘误》[《Heliyon》第9卷，第1期，2023年1月，文章编号e12599]
Heliyon. 2024 Nov 14;10(23):e40199. doi: 10.1016/j.heliyon.2024.e40199. eCollection 2024 Dec 15.
4
Corrigendum to "Use of aromatic plants and essential oils in the teaching of physics and chemistry to enhance motivation and sustainability awareness among primary education trainee teacher" [Heliyon Vol. 10, Iss. 15, August 2024, Article e35301].《关于“在物理和化学教学中使用芳香植物和精油以提高小学教育实习教师的学习动机和可持续发展意识”的勘误》[《Heliyon》第10卷，第15期，2024年8月，文章编号e35301]
Heliyon. 2024 Nov 14;10(22):e40343. doi: 10.1016/j.heliyon.2024.e40343. eCollection 2024 Nov 30.
5
Corrigendum to "Determinants of Minimum Dietary Diversity of Lactating Mothers in Rural Northern Region of Bangladesh: A Community-Based Cross-Sectional Study" [Heliyon Vol. 9, Iss 1,Jan. 2023, Article e12776].《孟加拉国北部农村地区哺乳期母亲最低饮食多样性的决定因素：一项基于社区的横断面研究》勘误 [《Heliyon》第9卷，第1期，2023年1月，文章编号e12776]
Heliyon. 2024 Dec 17;11(1):e41229. doi: 10.1016/j.heliyon.2024.e41229. eCollection 2025 Jan 15.
6
Corrigendum to "Production, optimization, and characterization of Ethiopian variant Prosopis juliflora based biodiesel" [Heliyon Volume 9, Issue 5, May 2023, Article e15721].《埃塞俄比亚变种牧豆树基生物柴油的生产、优化及特性研究》勘误 [《Heliyon》第9卷，第5期，2023年5月，文章编号e15721]
Heliyon. 2025 Mar 14;11(6):e43013. doi: 10.1016/j.heliyon.2025.e43013. eCollection 2025 Mar 20.
7
Corrigendum to "SOX8 promotes tumor growth and metastasis through FZD6-dependent Wnt/β-catenin signaling in colorectal carcinoma" [Heliyon 9(12) (December 2023) e22586].《“SOX8通过FZD6依赖的Wnt/β-连环蛋白信号通路促进结直肠癌的肿瘤生长和转移”的勘误》[《Heliyon》9(12)（2023年12月）e22586]
Heliyon. 2024 Jan 1;10(1):e23966. doi: 10.1016/j.heliyon.2023.e23966. eCollection 2024 Jan 15.
8
Corrigendum to "Transmissibility of the variant of concern for SARS-CoV-2 in six regions" [Heliyon Volume 10, Issue 11, June 15, 2024, Article e32164].《关于新型冠状病毒肺炎关切变异株在六个地区的传播性》勘误 [《Heliyon》第10卷，第11期，2024年6月15日，文章e32164]
Heliyon. 2025 Feb 26;11(4):e42892. doi: 10.1016/j.heliyon.2025.e42892. eCollection 2025 Feb 28.
9
Corrigendum to "Error rates in SARS-CoV-2 testing examined with Bayes' theorem" [Heliyon 7, (4), (April 2021), Article e06905].《用贝叶斯定理检验的SARS-CoV-2检测中的错误率》勘误[《Heliyon》7卷，（4）期，（2021年4月），文章编号e06905]
Heliyon. 2022 Feb;8(2):e08836. doi: 10.1016/j.heliyon.2022.e08836. Epub 2022 Jan 28.
10
Corrigendum to "Gilteritinib overcomes primary resistance to venetoclax in a patient with FLT3 wild-type refractory/relapsed AML: Case report and exploration of possible mechanisms" [Heliyon Volume 10, Issue 16, August 30, 2024, Article e35847].《吉瑞替尼克服FLT3野生型难治性/复发性急性髓系白血病患者对维奈克拉的原发性耐药：病例报告及可能机制探讨》勘误 [《Heliyon》第10卷，第16期，2024年8月30日，文章e35847]
Heliyon. 2025 Feb 16;11(4):e42725. doi: 10.1016/j.heliyon.2025.e42725. eCollection 2025 Feb 28.